Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
startups
abbvie
adalimumab (humira)
aducanumab
aduro biotech
affordable care act
alez azar
alzheimer's disease
andreessen-horowitz
antibiotics
axial spondyloarthritis
bausch health
big data
biogen
biology
boston blog main
boston top stories
boston university
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
business
cancer
cancer immunotherapy
car-t immunotherapy
cell therapy
clinical trials
cloud
cluster headache
crispr
deals
detroit blog main
detroit top stories
diagnostics
digital health
dihydroergotamine
dimitry nuyten
drug prices
eddingpharm
What
biopharmaceutical
3
×
new
3
×
drug
founder
million
startup
alto
andreessen
approval
artificial
bio
biogen’s
braintree
bryan
called
capital
celgene
cells
celularity
companies
company
convo
creating
derived
develop
diamandis
discovery
earlier
early
endeavor
failures
firm
focus
founded
fund
funding
gene
global
grow
hold
Language
Current search:
biopharmaceutical
×
new
×
@xconomy.com
4 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@venturebeat.com
6 years ago
TwoXar raises $10 million from SoftBank, Andreessen Horowitz, and OS Fund to grow its AI drug discovery platform
@techcrunch.com
6 years ago
With $250 million, Peter Diamandis’ new startup is all about taking stem cells from placentas
